dactinomycin has been researched along with Acute Myelogenous Leukemia in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (67.11) | 18.7374 |
1990's | 10 (13.16) | 18.2507 |
2000's | 5 (6.58) | 29.6817 |
2010's | 4 (5.26) | 24.3611 |
2020's | 6 (7.89) | 2.80 |
Authors | Studies |
---|---|
Brunetti, L; Cardinali, V; Falini, B; Gionfriddo, I; Marra, A; Martelli, MP; Milano, F; Perriello, VM; Pianigiani, G; Pierangeli, S; Ranieri, R; Sciabolacci, S | 1 |
Bertoli, S; Beziat, G; Bories, P; Delabesse, E; Huguet, F; Largeaud, L; Luquet, I; Récher, C; Rieu, JB; Tavitian, S; Vergez, F | 1 |
Berthier, C; Brunetti, L; Cardinali, V; Ciurnelli, R; de Thé, H; Dorillo, E; Falini, B; Falzetti, F; Gionfriddo, I; Griffin, MJ; Jennings, CE; Martelli, MP; Mezzasoma, F; Milano, F; Pierangeli, S; Ranieri, R; Spinozzi, G; Sportoletti, P; Tiacci, E; Veal, GJ; Venanzi, A; Vetro, C; Wu, HC | 1 |
Ades, L; Bazarbachi, A; Benhenda, S; Bénit, P; Berthier, C; Brunetti, L; Clappier, E; Conte, L; de Thé, H; Dombret, H; Durand, S; El Hajj, H; Espeli, O; Falini, B; Fenaux, P; Gachet, S; Hleihel, R; Ito, K; Itzykson, R; Kroemer, G; Lallemand-Breitenbach, V; Mak, TW; Martelli, MP; Morganti, C; Quentin, S; Raffoux, E; Rérolle, D; Rimsky, S; Rustin, P; Sakamoto, T; Sebert, M; Soulier, J; Souquere, S; Trowbridge, JJ; Wu, C; Wu, HC | 1 |
Abou Dalle, I; Bazarbachi, A | 1 |
Daraskevicius, J; Everatt, V; Maneikis, K; Ringeleviciute, U; Vaitekenaite, V; Zucenka, A | 1 |
Bi, K; Chen, F; Fan, J; Hou, M; Liu, G; Ran, X; Wang, J; Wang, L; Wang, M; Wang, X; Wang, Z; Xu, R; Yang, E; Yang, S; Yu, W; Zhao, H | 1 |
Maherus, EM; Rashidi, A | 1 |
Cao, Z; Gong, BF; Gong, XY; Gu, RX; Li, W; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Wang, JX; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL | 1 |
Brunetti, L; Falini, B; Martelli, MP | 1 |
Kim, KJ; Kim, YD; Lee, YH | 1 |
Houtenbos, I; Ossenkoppele, GJ; Schuurhuis, GJ; van de Loosdrecht, AA; Westers, TM | 1 |
Chang, LJ; Gamble, CL; Izaguirre, CA; Mak, TW; McCulloch, EA; Minden, MD | 1 |
Bloch, A; Craig, RW; Frankfurt, OS; Sakagami, H; Takeda, K | 1 |
AbdAllah, NA; Fisch, H; Flick, DA; Gifford, GE | 1 |
Ajmar, F; Barresi, R; Bianchi Scarrà, G; Garrè, C; Ravazzolo, R; Sessarego, M | 1 |
Fujita, Y; Honma, Y; Hozumi, M; Kasukabe, T; Nomura, H; Sakurai, M; Sampi, K; Tsushima, S | 1 |
Himori, T; Ohnuma, T; Wakui, A | 1 |
Kildahl-Andersen, O; Nissen-Meyer, J | 1 |
Abe, E; Konno, K; Kuribayashi, T; Miyaura, C; Nishii, Y; Suda, T; Tanaka, H | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E | 1 |
Bloch, A | 1 |
Herwig, S; Ma, Y; Su, Q; Tempst, P; Zhang, W | 1 |
Aplan, PD; Chervinsky, DS; Stanulla, M; Wang, J | 1 |
Hirokawa, M; Kitabayashi, A; Miura, AB; Mori, S; Moriyama, M; Onizuka, T; Yamochi, T | 1 |
Ahrens, S; Dunst, J; Harms, D; Jürgens, H; Paulussen, M; Rübe, C; Winkelmann, W; Zoubek, A | 1 |
Pallis, M; Russell, NH; Syan, J | 1 |
Abe, T; Aizawa, Y; Fuse, I; Hashimoto, S; Itoh, H; Koike, T; Shibazaki, Y; Takahashi, H; Takahashi, M; Toba, K; Watanabe, K; Yano, T | 1 |
Pallis, M; Russell, N | 1 |
Appelbaum, FR; Banker, DE; Garrido, SM; Willman, C | 1 |
Bocaccino, CA; Greenberger, JS; Moloney, WC; Szot, SJ | 1 |
Frengley, PA; Lichtman, MA; Peck, WA | 2 |
Fekete, B; Hadházy, G; Szabó, B; Szabó, G | 1 |
Hayashi, M; Honma, Y; Hozumi, M; Okabe, J | 1 |
Sieber, SM | 1 |
Davies, JE; Khurshid, M; Whittaker, JA | 1 |
Bernengo, MG; Pegoraro, L | 1 |
Cadossi, R; Ferrari, S; Montagnani, G; Narni, F; Torelli, G; Torelli, U | 1 |
Augustinos, P; Baer, MR; Kinniburgh, AJ | 1 |
Holte, H; Lie, SO; Smeland, EB; Steen, HB; Stokke, T | 1 |
Durham, J; Fontana, J; Munoz, M | 1 |
Confer, DL; Schubach, WH; Slungaard, A | 1 |
Hozumi, M | 1 |
Bauters, F; Fenaux, P; Jouet, JP; Lai, JL; Lepelley, P | 1 |
Lin, J; Sartorelli, AC | 1 |
Bertani, A; Colotta, F; Mantovani, A; Polentarutti, N; Rambaldi, A; Sica, A | 1 |
Brajtburg, J; Medoff, G; Vertut-Croquin, A | 1 |
Honma, Y; Hozumi, M; Kasukabe, T; Nishii, Y; Suda, T | 1 |
Ciomei, M; Giuliani, FC; Pastori, W | 1 |
Carter, SP; Darzynkiewicz, Z; Old, LJ | 1 |
Arlin, Z; Chiao, JW; Choi, YS; Heil, M; Leung, K; Lutton, JD | 1 |
Bagby, GC; Gowda, SD; Koler, RD | 1 |
Hirji, K; Koeffler, HP; Prokocimer, M; Yelton, L | 1 |
Berrebi, A; Lotem, J; Sachs, L | 1 |
Honma, Y; Hozumi, M; Sakurai, M; Sampi, K | 1 |
Fibach, E; Korenberg, A; Rachmilewitz, EA; Treves, A | 1 |
Brachet, J; Hulin, N; Masera, P; Pileri, A | 1 |
Aye, MT; Mak, TW; McCulloch, EA; Messner, H; Sheinin, R; Till, JE | 1 |
Danieli, G | 1 |
Bolognesi, DP; Green, RW; Metzgar, RS; Miller, DS; Mohanakumar, T | 1 |
Garbarino, G; Hulin, N; Masera, P; Pileri, A | 1 |
Beard, JW; Bonar, RA; Langlois, AJ; Rao, PR; Zischka, R | 1 |
Beard, JW; Heine, U; Langlois, AJ | 1 |
Zubrod, CG | 1 |
Gergely, L; Hadházy, G; Szegedi, G; Tóth, FD | 1 |
Berebbi, M; Carcassonne, Y; Foa, C; Meyer, G | 1 |
Hustinx, TW; Rutten, FJ; Scheres, JM; Wagener, DJ | 1 |
De Pasquale, A; Emilia, G; Ferreira, E; Mauri, C; Quaglino, D | 1 |
Maugel, TK; McFeely, AE; Schumacher, HR | 1 |
Chan, BW | 2 |
Emilia, G; Grossi, G; Quaglino, D; Sauli, S | 1 |
Bernardelli, R; Brusa, L; Gavosto, F; Pileri, A; Tarocco, RP | 2 |
Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakazawa, N; Ohgawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
3 review(s) available for dactinomycin and Acute Myelogenous Leukemia
Article | Year |
---|---|
Current status and future perspectives in targeted therapy of NPM1-mutated AML.
Topics: Adult; Dactinomycin; Histones; Humans; Leukemia, Myeloid, Acute; Mutation; Nuclear Proteins; Nucleophosmin; Proto-Oncogene Proteins c-bcl-2; Receptors, Antigen, T-Cell; RNA | 2022 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Prednisone; Pregnancy; Procarbazine; Time Factors; Vincristine | 1977 |
[Induction of the differentiation of tumor cells as an approach to tumor therapy].
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Dactinomycin; Etretinate; Humans; Interferons; Interleukin-3; Leukemia, Experimental; Leukemia, Myeloid, Acute; Neoplasms | 1987 |
3 trial(s) available for dactinomycin and Acute Myelogenous Leukemia
Article | Year |
---|---|
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Topics: Aged; Antibiotics, Antineoplastic; Cell Nucleolus; Dactinomycin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Nuclear Proteins; Nucleophosmin; Pilot Projects; Prognosis; Remission Induction; Salvage Therapy | 2021 |
[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Remission Induction | 2014 |
[Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Bronchitis; Cefozopran; Cephalosporins; Female; Granulocytes; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peritonitis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Severity of Illness Index | 1998 |
70 other study(ies) available for dactinomycin and Acute Myelogenous Leukemia
Article | Year |
---|---|
Dactinomycin in acute myeloid leukemia with NPM1 mutations.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biomarkers, Tumor; Dactinomycin; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Prognosis; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.
Topics: Dactinomycin; Humans; Leukemia, Myeloid, Acute; Mitochondria; Nuclear Proteins; Nucleophosmin | 2021 |
Successful venetoclax and Actinomycin D-based treatment for relapsed acute myeloid leukemia post allogeneic hematopoietic cell transplantation.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Dactinomycin; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Sulfonamides | 2021 |
Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Dactinomycin; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Retrospective Studies; Salvage Therapy; Sulfonamides; Survival Rate | 2021 |
After the treated mole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunophenotyping; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Second Primary; Pregnancy; Trophoblasts; Vincristine | 2014 |
[Efficacy Analysis of MAC Regimen as Salvage Treatment Protocol for Acute Myeloid Leukemia Patients Older Than 55 Years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cytarabine; Dactinomycin; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Recurrence; Remission Induction; Salvage Therapy | 2015 |
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Bone Marrow Examination; Dactinomycin; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin | 2015 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometry.
Topics: Apoptosis; Biomarkers, Tumor; CD28 Antigens; Cell Death; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Dactinomycin; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid, Acute; T-Lymphocytes; U937 Cells | 2005 |
Detection of genes coding for human differentiation markers by their transient expression after DNA transfer.
Topics: Animals; Antibodies, Monoclonal; Cell Differentiation; Cells, Cultured; Cycloheximide; Dactinomycin; DNA Restriction Enzymes; DNA, Neoplasm; Fluorescent Antibody Technique; Kinetics; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Protein Biosynthesis; Transcription, Genetic; Transfection | 1982 |
Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
Topics: Cell Cycle; Cell Differentiation; Cell Line; Cycloheximide; Cytarabine; Dactinomycin; Daunorubicin; DNA Replication; Humans; Kinetics; Leucine; Leukemia, Myeloid, Acute; Protein Biosynthesis; Thymidine; Transcription, Genetic; Tretinoin; Tritium; Uridine | 1984 |
Production of a cytotoxin from phorbol myristate acetate-treated human promyelocytes.
Topics: Animals; Cell Line; Cytotoxins; Dactinomycin; Embryo, Mammalian; Fibroblasts; HeLa Cells; Humans; Kinetics; L Cells; Leukemia, Myeloid, Acute; Mice; Phorbols; Skin; Skin Physiological Phenomena; Tetradecanoylphorbol Acetate | 1984 |
Regulation of acetylcholinesterase expression in the K-562 cell line.
Topics: Acetylcholinesterase; Butyrates; Butyric Acid; Cell Division; Cell Line; Cycloheximide; Dactinomycin; Enzyme Induction; Humans; Kinetics; Leukemia, Myeloid, Acute | 1984 |
Differentiation in vitro of human myelogenous leukemia cells from patients in relapse.
Topics: Adolescent; Adult; Aged; Cell Differentiation; Cells, Cultured; Dactinomycin; Female; Humans; Leukemia, Myeloid, Acute; Lysophospholipids; Male; Middle Aged; Phospholipids | 1984 |
[Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
Topics: Anthraquinones; Antineoplastic Agents; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Phagocytes; Thioguanine; Vincristine | 1984 |
Effect of lymphokines on the production of cytostatic protein factors from human monocytes.
Topics: Adult; Cell Division; Cell Line; Cells, Cultured; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; Humans; Kinetics; Leukemia, Myeloid, Acute; Lipopolysaccharides; Lymphocytes; Lymphokines; Monocytes; Protein Biosynthesis; Proteins | 1984 |
1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells.
Topics: Calcitriol; Cell Differentiation; Cell Line; Dactinomycin; Dimethyl Sulfoxide; Humans; Kinetics; Leukemia, Myeloid, Acute; Tetradecanoylphorbol Acetate | 1981 |
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1993 |
Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Differentiation; Cytarabine; Cytokines; Dactinomycin; Daunorubicin; DNA, Neoplasm; Drug Synergism; Humans; Leukemia, Myeloid, Acute; Monocytes; Transforming Growth Factor beta; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1993 |
Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Topics: Acetamides; Biomarkers; Blood Proteins; Cell Differentiation; Cycloheximide; Cytokines; Dactinomycin; Defensins; Dimethyl Sulfoxide; Dimethylformamide; DNA, Complementary; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Genistein; Granulocyte Colony-Stimulating Factor; Granulocytes; HL-60 Cells; Humans; Interferon-gamma; Isoflavones; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Recombinant Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus.
Topics: Amsacrine; Antineoplastic Agents; Base Sequence; Cell Line; Dactinomycin; DNA Damage; DNA, Neoplasm; Doxorubicin; Etoposide; Genes, abl; Humans; Leukemia, Myeloid, Acute; Molecular Sequence Data; Monocytes; Restriction Mapping; Topoisomerase II Inhibitors; Translocation, Genetic | 1997 |
Regulation of BCL-6 gene expression in human myeloid/monocytoid leukemic cells.
Topics: Adult; Cell Differentiation; Cell Nucleus; Cycloheximide; Dactinomycin; DNA-Binding Proteins; Flow Cytometry; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Tetradecanoylphorbol Acetate; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy Dosage; Sarcoma; Sarcoma, Ewing; Time Factors; Vincristine | 1998 |
Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
Topics: Antibodies; Antigens, CD34; Cell Count; Cytarabine; Dactinomycin; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Light; Myelodysplastic Syndromes; Scattering, Radiation; Sensitivity and Specificity; Stem Cells; Tumor Cells, Cultured | 1999 |
Cell kinetic study of normal human bone marrow hematopoiesis and acute leukemia using 7AAD/PY.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Cells; Burkitt Lymphoma; Cell Cycle; Cells, Cultured; Dactinomycin; DNA; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunophenotyping; Kinetics; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA | 2000 |
P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blast Crisis; Cell Survival; Ceramides; Cyclosporins; Dactinomycin; Flow Cytometry; Fluorescent Dyes; Genes, MDR; Growth Substances; Humans; Kinetics; Leukemia, Myeloid, Acute; Signal Transduction; Sphingomyelins; Tumor Cells, Cultured; U937 Cells | 2000 |
Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
Topics: Antibodies; Antigens, CD34; Antineoplastic Agents; Apoptosis; Color; Dactinomycin; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; G1 Phase; Humans; Immunophenotyping; K562 Cells; Leukemia, Myeloid, Acute; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; S Phase | 2000 |
Chemotherapeutic remissions in Wistar Furth rat acute myelogenous leukemia: a model for human AML.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Dexamethasone; Disease Models, Animal; Doxorubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Methotrexate; Rats; Remission, Spontaneous; Vinblastine; Vincristine | 1977 |
Adaptive enhancement of amino acid transport in human leukemia leukocytes: studies with alpha-aminoisobutyric acid.
Topics: Acute Disease; Adenosine Triphosphate; Aminoisobutyric Acids; Cell Membrane; Cyclic AMP; Cycloheximide; Dactinomycin; Extracellular Space; Humans; Intracellular Fluid; Kinetics; Leucine; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Proteins; Time Factors | 1975 |
Interferon production by human leukaemic leucocytes.
Topics: Adult; Aged; Cells, Cultured; Child; Child, Preschool; Cycloheximide; Dactinomycin; Humans; Immunosuppressive Agents; Interferons; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Middle Aged; Parainfluenza Virus 1, Human; Puromycin | 1976 |
Actinomycin D restores in vivo sensitivity to differentiation induction of non-differentiating mouse myeloid leukemia cells.
Topics: Animals; Cell Differentiation; Cell Line; Cells, Cultured; Clone Cells; Dactinomycin; Female; Granulocytes; Immunization; Leukemia, Experimental; Leukemia, Myeloid, Acute; Macrophages; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Phagocytosis; Transplantation, Isogeneic | 1979 |
The effect of cytotoxic drugs on neutrophil phagocytosis in vitro and in patients with acute myelogenous leukaemia.
Topics: Antineoplastic Agents; Candida albicans; Cell Survival; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neutrophils; Phagocytosis | 1976 |
Deoxycytidylate deaminase activity and its template stability in human acute lymphoblastic and myeloblastic leukaemic cells.
Topics: Adult; Aged; Child; Child, Preschool; Dactinomycin; DCMP Deaminase; Enzyme Activation; Female; Histocytochemistry; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Lymphocyte Activation; Male; Middle Aged; Nucleotide Deaminases; RNA; Templates, Genetic | 1976 |
Accumulation of giant heterogeneous RNA molecules in acute myeloid leukemia blast cells.
Topics: Dactinomycin; Humans; Kinetics; Leukemia, Myeloid, Acute; Lymphocyte Activation; Lymphocytes; Molecular Weight; Poly A; RNA, Neoplasm; RNA, Ribosomal | 1976 |
Defective c-myc and c-myb RNA turnover in acute myeloid leukemia cells.
Topics: Adult; Aged; Blotting, Northern; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, myc; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myb; RNA; Transcription, Genetic | 1992 |
Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells.
Topics: Antigens, CD; Cell Cycle; Child; Chromatin; Dactinomycin; DNA; Flow Cytometry; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Transcription, Genetic | 1992 |
Potentiation between intracellular cyclic-AMP-elevating agents and inducers of leukemic cell differentiation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Differentiation; Cell Line; Cholera Toxin; Cyclic AMP; Dactinomycin; Dimethylformamide; Drug Synergism; Humans; Hypoxanthine; Hypoxanthines; Leukemia, Myeloid, Acute; Time Factors; Tretinoin | 1985 |
Rapid transcriptional down-regulation of c-myc expression during cyclic adenosine monophosphate-promoted differentiation of leukemic cells.
Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Cell Differentiation; Cell Line; Cholera Toxin; Cyclic AMP; Dactinomycin; Deoxyribonuclease I; Gene Expression Regulation; Humans; Leukemia, Myeloid, Acute; Oncogenes; RNA; Transcription, Genetic | 1987 |
Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Translocation, Genetic | 1987 |
Stimulation by interferon of the differentiation of human promyelocytic leukemia (HL-60) cells produced by retinoic acid and actinomycin D.
Topics: Aclarubicin; Cell Differentiation; Cell Division; Cell Line; Dactinomycin; Drug Synergism; Humans; Interferons; Leukemia, Myeloid, Acute; Naphthacenes; Tretinoin | 1987 |
Expression of c-jun protooncogene in human myelomonocytic cells.
Topics: Cells, Cultured; Cycloheximide; Dactinomycin; DNA-Binding Proteins; Gene Expression; Humans; Leukemia, Myeloid, Acute; Lipopolysaccharides; Monocytes; Neutrophils; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Proto-Oncogenes; Recombinant Proteins; Reference Values; RNA; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Necrosis Factor-alpha | 1989 |
Two mechanisms of synergism when amphotericin B is used in combination with actinomycin D or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea against the human promyelocytic leukemia cell line HL-60.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cell Line; Dactinomycin; Drug Synergism; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Lomustine; Malondialdehyde; Oxidation-Reduction; Potassium; Thymidine | 1986 |
Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cell Differentiation; Cell Division; Cytarabine; Dactinomycin; Daunorubicin; Dexamethasone; Hydroxycholecalciferols; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Time Factors | 1987 |
The influence of amphotericin B on differentiation induced by dimethylsulfoxide and actinomycin D in HL60 and Friend cell lines.
Topics: Amphotericin B; Cell Differentiation; Cell Division; Cell Line; Dactinomycin; Dimethyl Sulfoxide; Drug Synergism; Friend murine leukemia virus; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute | 1986 |
Effect of recombinant tumor necrosis factor on HL-60 cells: cell-cycle specificity and synergism with actinomycin D.
Topics: Cell Cycle; Cell Division; Cell Line; Cell Survival; Dactinomycin; Drug Synergism; Glycoproteins; Humans; Kinetics; Leukemia, Myeloid, Acute; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1987 |
Suppression of lymphocyte activation and functions by a leukemia cell-derived inhibitor.
Topics: Cell Differentiation; Cell Line; Dactinomycin; Humans; Immune Tolerance; Interleukin-2; Leukemia, Myeloid, Acute; Lymphocyte Activation; Lymphokines | 1986 |
Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells.
Topics: Bone Marrow Cells; Cell Differentiation; Cell Division; Cell Line; Culture Media; Dactinomycin; Growth Substances; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Nucleic Acid Hybridization; Pregnancy Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins | 1986 |
Study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate.
Topics: Adult; Aged; Cell Differentiation; Cell Line; Dactinomycin; Dimethyl Sulfoxide; Humans; Hypoxanthine; Hypoxanthines; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Middle Aged; Nitroblue Tetrazolium; Phagocytosis; Thioguanine | 1985 |
Screening for induction of differentiation and toxicity to blast cells by chemotherapeutic compounds in human myeloid leukemia.
Topics: Antineoplastic Agents; Bone Marrow; Cell Differentiation; Cells, Cultured; Dactinomycin; Drug Evaluation, Preclinical; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Time Factors | 1985 |
Discrepancy between in-vitro and in-vivo inductions of differentiation by retinoids of human acute promyelocytic leukemia cells in relapse.
Topics: Cell Differentiation; Dactinomycin; Humans; In Vitro Techniques; Leukemia, Myeloid, Acute; Male; Middle Aged; Tretinoin | 1985 |
In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs.
Topics: Antimetabolites; Antimetabolites, Antineoplastic; Cell Line; Dactinomycin; Disseminated Intravascular Coagulation; Granulocytes; Humans; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Puromycin; Thromboplastin | 1985 |
[The activity of chromatin of normal and leukemic leukocytes].
Topics: Autoradiography; Binding Sites; Cell Nucleus; Chromosomes; Dactinomycin; DNA; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Methotrexate; Staining and Labeling; Tritium | 1970 |
Reverse transcriptase activity: increase in marrow cultures from leukaemic patients in relapse and remission.
Topics: Bone Marrow; Bone Marrow Cells; Cells, Cultured; Dactinomycin; DNA, Neoplasm; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Remission, Spontaneous; RNA-Directed DNA Polymerase; RNA, Neoplasm; Tritium | 1974 |
[1973 treatment of acute leukemias].
Topics: Chlorambucil; Colchicine; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Vinblastine; Vincristine | 1974 |
Human leukemia antigens: partial isolation and characterization.
Topics: Animals; Antigens, Neoplasm; Cell Line; Cell Membrane; Centrifugation; Chromatography, Gel; Cycloheximide; Cytarabine; Cytotoxicity Tests, Immunologic; Dactinomycin; Haplorhini; Histocompatibility Antigens; Humans; Immune Sera; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Lymphocytes; Microscopy, Electron; Neuraminidase; Papain; Potassium Chloride; Pronase; Puromycin; Rabbits; Subcellular Fractions; Temperature; Trypsin | 1974 |
Myeloid cell actinomycin binding in human myeloid leukaemia.
Topics: Autoradiography; Binding Sites; Bone Marrow; Bone Marrow Cells; Chromatin; Dactinomycin; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Methotrexate; Tritium | 1974 |
Effects of actinomycin D on avian myeloblast and BAI strain A virus RNA synthesis in vitro.
Topics: Avian Leukosis Virus; Bone Marrow; Bone Marrow Cells; Culture Techniques; Dactinomycin; Leukemia, Myeloid, Acute; RNA, Viral | 1966 |
Ultrastructural alterations in avian leukemia myeloblasts exposed to actinomycin D in vitro.
Topics: Animals; Avian Leukosis Virus; Bone Marrow; Bone Marrow Cells; Culture Techniques; Dactinomycin; Leukemia, Myeloid, Acute; Poultry; RNA, Viral | 1966 |
Acute leukemias and Burkitt's lymphoma. Present status of therapy.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Melphalan; Mercaptopurine; Methotrexate; Prednisone; Pregnancy; Vincristine; Wilms Tumor | 1968 |
Comparative study on the interferon production by the leukocytes of healthy and leukaemic subjects.
Topics: Amnion; Culture Techniques; Dactinomycin; Humans; Interferons; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Newcastle disease virus; Parainfluenza Virus 1, Human; RNA, Neoplasm; Viral Interference | 1967 |
[Characterization of a hybrid cell line, "human leukemia-Chinese hamster"].
Topics: Animals; Azaguanine; Cell Line; Cricetinae; Dactinomycin; Fibroblasts; Fluorescent Antibody Technique; Genotype; Humans; Hybrid Cells; Karyotyping; Leukemia, Myeloid, Acute; Mitosis; Parainfluenza Virus 1, Human; Selection, Genetic | 1973 |
Trisomy-9 in the bone marrow of a patient with acute myelomonoblastic leukaemia.
Topics: Adult; Autopsy; Bone Marrow Cells; Chromosomes, Human, 6-12 and X; Cytarabine; Dactinomycin; Hemorrhage; Histocytochemistry; Humans; Kidney Neoplasms; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Neoplasm Metastasis; Radiotherapy; Trisomy; Wilms Tumor | 1974 |
Accelerated active transport of alpha aminoisobutyric acid by human leukemic leukocytes in an amino acid deficient environment.
Topics: Alanine; Amino Acids; Aminoisobutyric Acids; Biological Transport, Active; Carbon Radioisotopes; Cells, Cultured; Culture Media; Cycloheximide; Dactinomycin; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Lymphocytes; Sucrose; Time Factors | 1974 |
Relationship between RNA metabolism and cell cycle in acute leukaemia.
Topics: Acute Disease; Autoradiography; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Dactinomycin; Humans; Lectins; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphocytes; RNA; Tritium; Uridine | 1972 |
The mononucleosis and leukemic cell. II. RNA synthesis.
Topics: Autoradiography; Dactinomycin; Humans; In Vitro Techniques; Infectious Mononucleosis; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; RNA; Tritium; Uridine | 1968 |
Autoradiographic studies of RNA metabolism in human leukaemic blast cells.
Topics: Autoradiography; Bone Marrow; Bone Marrow Cells; Culture Techniques; Dactinomycin; DNA; Humans; Leucine; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; RNA; Tritium; Uridine | 1971 |
RNA and protein synthesis in proliferating and non-proliferating blast cells of human acute leukaemia.
Topics: Autoradiography; Blood Cells; Blood Proteins; Bone Marrow; Bone Marrow Cells; Cell Division; Culture Techniques; Dactinomycin; DNA; Humans; Leucine; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; RNA; Thymidine; Tritium; Uridine | 1971 |
[Cytoautoradiographic research on cells of acute leukemia].
Topics: Autoradiography; Blood Cells; Dactinomycin; DNA; Humans; Leucine; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukemia, Plasma Cell; Proteins; RNA; Thymidine; Uridine | 1968 |
Degradation of RNA and changes in protein metabolism in human acute leukaemia cells treated with actinomycin D.
Topics: Dactinomycin; Humans; Leucine; Leukemia; Leukemia, Myeloid, Acute; Proteins; RNA; Time Factors; Tritium; Uridine | 1967 |
Changes in protein metabolism in proliferating and non-proliferating human acute leukaemia cells treated with actinomycin-D.
Topics: Blood Proteins; Dactinomycin; Depression, Chemical; Humans; In Vitro Techniques; Leucine; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphocytes; RNA; Tritium | 1969 |